LEADER 05482oam 2200877M 450 001 9910455928003321 005 20200324081355.0 010 $a0-429-09286-5 010 $a1-4200-4526-1 035 $a(CKB)2440000000014930 035 $a(EBL)3059669 035 $a(OCoLC)922955687 035 $a(SSID)ssj0000389697 035 $a(PQKBManifestationID)11246088 035 $a(PQKBTitleCode)TC0000389697 035 $a(PQKBWorkID)10449560 035 $a(PQKB)10001048 035 $a(SSID)ssj0000389698 035 $a(PQKBManifestationID)11938201 035 $a(PQKBTitleCode)TC0000389698 035 $a(PQKBWorkID)10448433 035 $a(PQKB)10662347 035 $a(MiAaPQ)EBC3059669 035 $a(MiAaPQ)EBC1398211 035 $a(Au-PeEL)EBL3059669 035 $a(CaPaEBR)ebr10231564 035 $a(CaONFJC)MIL787611 035 $a(OCoLC)1055657913 035 $a(OCoLC-P)1055657913 035 $a(FlBoTFG)9780429092862 035 $a(Au-PeEL)EBL1398211 035 $a(OCoLC)905983838 035 $a(EXLCZ)992440000000014930 100 $a20170131d2008 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aModified-Release Drug Delivery Technology, Second Edition $eModified Release Drug Delivery Technology, Volume 2 205 $a2nd ed. 210 1$aNew York :$cCRC Press,$d2008. 210 4$d©2013 215 $a1 online resource (727 p.) 225 1 $aDrugs and the pharmaceutical sciences ;$v184 300 $aDescription based upon print version of record. 311 $a1-84184-928-6 311 $a1-4200-5355-8 320 $aIncludes bibliographical references and indexes. 327 $a""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulationa???PLAD Technology"" 327 $a""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" 327 $a""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" 327 $a""27 LidoSitea???Vyteris Iontophoretic Technology""""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" 327 $a""37 Phospholipids as Carriers for Vaginal Drug Delivery""""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" 327 $a""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" 410 0$aDrugs and the pharmaceutical sciences ;$v184. 606 $aControlled release technology 606 $aControlled release preparations 606 $aDrug delivery systems 606 $aPharmaceutical technology 608 $aElectronic books. 615 0$aControlled release technology. 615 0$aControlled release preparations. 615 0$aDrug delivery systems. 615 0$aPharmaceutical technology. 676 $a615/.19 700 $aRathbone$b Michael J$0318416 701 $aHadgraft$b Jonathan$0846522 701 $aRoberts$b Michael S$078377 701 $aLane$b Majella E$0846523 801 0$bOCoLC-P 801 1$bOCoLC-P 906 $aBOOK 912 $a9910455928003321 996 $aModified-Release Drug Delivery Technology, Second Edition$91891368 997 $aUNINA LEADER 01270nam0 22002771i 450 001 UON00328025 005 20231205104208.734 100 $a20090728d1955 |0itac50 ba 101 $ager 102 $aAT 105 $a|||| ||||| 200 1 $aReichspatriotismus und reichspolitik zur zeit des prager friedens von 1635$eeine studie zur geschichte des deutschen nationalbewubtseins$fAdam Wandruszka 210 $aGraz$aKöln$cHermann Böhlaus Nachf.$d1955 215 $a116 p.$d21 cm. 410 1$1001UON00328023$12001 $aVeröffentlichungen des Instituts für Österreichische Geschichtsforschung$fherausgegeben von Leo Santifaller$v17 606 $aGERMANIA$xSTORIA$xSEC. 17.$3UONC072484$2FI 620 $aAT$dGraz$3UONL000287 620 $aDE$dKöln$3UONL005641 700 1$aWANDRUSZKA$bAdam$3UONV112666$0155114 712 $aBöhlaus$3UONV260054$4650 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00328025 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI III STORIAEUR C C 0204 $eSI MR 46569 5 0204 996 $aReichspatriotismus und reichspolitik zur zeit des prager friedens von 1635$91368844 997 $aUNIOR